0000899866-21-000022.txt : 20210302 0000899866-21-000022.hdr.sgml : 20210302 20210302174855 ACCESSION NUMBER: 0000899866-21-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bazarko Daniel CENTRAL INDEX KEY: 0001768214 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 21705586 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS, INC. STREET 2: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 4752302596 MAIL ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960111 4 1 wf-form4_161472530356155.xml FORM 4 X0306 4 2021-02-28 0 0000899866 ALEXION PHARMACEUTICALS, INC. ALXN 0001768214 Bazarko Daniel C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARD BOSTON MA 02210 0 1 0 0 SVP, Controller, CAO Common Stock, par value $.0001 per share 2021-02-28 4 A 0 7616 0 A 38499 D Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vests on each anniversary of the grant date. /s/ Douglas Barry, Attorney-in-Fact for Daniel Bazarko 2021-03-02